Global Allergy Immunotherapy Competitive Landscape Professional Research Report 2025
Research SummaryAllergy immunotherapy, also known as allergy shots or desensitization therapy, is a medical treatment aimed at reducing the symptoms and sensitivity associated with allergies, particularly allergic rhinitis (hay fever), asthma, and certain insect sting allergies. This therapy involves the administration of gradually increasing doses of allergens, such as pollen, dust mites, or pet dander, to an allergic individual over a period of time. The goal is to desensitize the immune system's exaggerated response to these allergens, ultimately reducing allergic symptoms and the need for allergy medications. Allergy immunotherapy can be administered through subcutaneous injections (allergy shots) or sublingual tablets or drops. Over time, the immune system becomes less reactive to the allergens, resulting in improved tolerance and reduced allergic reactions. It is an effective long-term treatment for many people with allergies, potentially offering lasting relief and improving their quality of life.
According to DIResearch's in-depth investigation and research, the global Allergy Immunotherapy market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Allergy Immunotherapy include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Allergy Immunotherapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Allergy Immunotherapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Allergy Immunotherapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Allergy Immunotherapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Allergy Immunotherapy Include:
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti
Allergy Immunotherapy Product Segment Include:
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Immunotherapy Product Application Include:
Allergic Rhinitis
Allergic Asthma
Others
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Allergy Immunotherapy Industry PESTEL Analysis
Chapter 3: Global Allergy Immunotherapy Industry Porter’s Five Forces Analysis
Chapter 4: Global Allergy Immunotherapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global Allergy Immunotherapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Allergy Immunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Allergy Immunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Allergy Immunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Allergy Immunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Allergy Immunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Allergy Immunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Allergy Immunotherapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources